VOYA INVESTMENT MANAGEMENT LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$880,858
-84.0%
32,331
-86.9%
0.00%
-85.7%
Q2 2023$5,504,005
-22.2%
247,371
-24.3%
0.01%
-22.2%
Q1 2023$7,076,170
+200.0%
326,693
+181.3%
0.01%
+200.0%
Q4 2022$2,358,641
-20.2%
116,132
+0.7%
0.00%
-25.0%
Q3 2022$2,957,343
-47.7%
115,341
-51.5%
0.00%
-71.4%
Q2 2022$5,656,000
+592.3%
237,861
+555.6%
0.01%
+600.0%
Q1 2022$817,000
+10.0%
36,279
-3.3%
0.00%
+100.0%
Q4 2021$743,000
-1.6%
37,536
-2.2%
0.00%
-50.0%
Q3 2021$755,000
-13.1%
38,368
-2.9%
0.00%0.0%
Q2 2021$869,000
-29.1%
39,502
-23.3%
0.00%0.0%
Q1 2021$1,225,000
-11.7%
51,505
-2.8%
0.00%
-33.3%
Q4 2020$1,387,000
+43.7%
53,014
-4.4%
0.00%
+50.0%
Q3 2020$965,000
+2.7%
55,426
-0.8%
0.00%0.0%
Q2 2020$940,000
+12.3%
55,876
-20.7%
0.00%0.0%
Q1 2020$837,0000.0%70,421
+1.8%
0.00%0.0%
Q4 2019$837,000
-4.7%
69,146
+11.4%
0.00%0.0%
Q3 2019$878,000
+26.5%
62,087
-0.3%
0.00%
+100.0%
Q2 2019$694,000
-7.0%
62,279
-2.0%
0.00%
-50.0%
Q1 2019$746,000
-14.6%
63,568
-2.8%
0.00%0.0%
Q4 2018$874,000
-13.2%
65,400
-8.9%
0.00%0.0%
Q3 2018$1,007,000
-10.8%
71,8010.0%0.00%0.0%
Q2 2018$1,129,000
-6.1%
71,801
-1.8%
0.00%
-33.3%
Q1 2018$1,202,000
-10.7%
73,083
-2.0%
0.00%0.0%
Q4 2017$1,346,000
+67.6%
74,549
+79.2%
0.00%
+50.0%
Q3 2017$803,000
+63.5%
41,5980.0%0.00%
+100.0%
Q2 2017$491,000
+57.4%
41,598
+46.2%
0.00%0.0%
Q1 2017$312,000
+50.7%
28,4530.0%0.00%
Q4 2016$207,000
+11.9%
28,4530.0%0.00%
Q3 2016$185,000
+19.4%
28,4530.0%0.00%
Q2 2016$155,000
+16.5%
28,4530.0%0.00%
Q1 2016$133,000
-6.3%
28,4530.0%0.00%
Q4 2015$142,000
+32.7%
28,4530.0%0.00%
Q3 2015$107,000
-37.4%
28,4530.0%0.00%
Q2 2015$171,00028,4530.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders